This suggests that the change in inflammatory mediators IL-2, IFN-y, and PGE2 explains an additional 39 % of the variability in the change in sensory neuropathic pain scores when the change in CES-D scores of depression has been statistically controlled for. The gene discussed is IL2; the disease is major depressive disorder.